Stapenor retard
Stapenor retard
Authorised
- Oxacillin sodium monohydrate
- Oxacillin benzathine
Product identification
Medicine name:
Stapenor retard
Active substance:
- Oxacillin sodium monohydrate
- Oxacillin benzathine
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Oxacillin sodium monohydrate219.90/milligram(s)1.00Applicator
-
Oxacillin benzathine1039.50/milligram(s)1.00Applicator
Pharmaceutical form:
-
Intramammary ointment
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle
-
Milk5daybei einer Trockenstehzeit von > 55 Tagen. Bei abweichender Trockenstehzeit und für weitere Hinweise s. SPC.
-
Meat and offal21day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51CF04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Wirtschaftsgenossenschaft deutscher Tieraerzte eG
Marketing authorisation date:
Manufacturing sites for batch release:
- Wirtschaftsgenossenschaft deutscher Tieraerzte eG
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 6294119.00.00
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 2/01/2025